MYIA
CC icon

Mount Yale Investment Advisors’s Chemours CC Stock Holding History

Mount Yale Investment Advisors’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,567
Closed -$207K – 321
2019
Q1 		$207K Buy
+5,567
New +$203K 0.04% 287
2018
Q4 		– Sell
-1,500
Closed -$52K – 389
2018
Q3 		$52K Buy
+1,500
New +$65.6K 0.01% 588

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mount Yale Investment Advisors's CC Position: Q2 2019 in Review

Mount Yale Investment Advisors sold out of Chemours (CC) in Q2 2019, closing a stake of 5,567 shares — an estimated $207K sold.

Mount Yale Investment Advisors first reported a position in CC in Q3 2018 and held it in 2 quarters. The position peaked at $207K in Q1 2019. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

  • Mount Yale Investment Advisors reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 5,567 Chemours shares in Q2 2019, an estimated $207K.
  • Mount Yale Investment Advisors first reported a position in Chemours in Q3 2018 and held it in 2 quarters.
  • Mount Yale Investment Advisors's Chemours position peaked at $207K in Q1 2019.
  • 488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.